policies >  DOI:10.25504/FAIRsharing.d8fvz
FAIRsharing is now available for record creation, update, and search at https://beta.fairsharing.org, please visit us there! Replacement of this read-only version of the legacy site with the new version of FAIRsharing is planned for the week commencing 31 January 2022.

ready Elsevier - Lancet Oncology - Information for Authors

General Information

Homepage https://www.thelancet.com/lanonc/about

Countries that developed this resource China , United Kingdom , United States

Published in 2000

Type: Journal


The Information for Authors page contains a broad range of guidelines for publishing in Lancet Oncology. With regards to data deposition, novel gene sequences should be deposited in a public database (GenBank, EMBL, or DDBJ), and the accession number provided. Authors of microarray papers should include in their submission the information recommended by the MIAME guidelines. Authors should also submit their experimental details to one of the publicly available databases: ArrayExpress or GEO.

Taxonomic range

How to cite this record FAIRsharing.org: Elsevier - Lancet Oncology - Information for Authors; DOI: https://doi.org/10.25504/FAIRsharing.d8fvz; Last edited: Feb. 18, 2020, 5:39 p.m.; Last accessed: Jan 26 2022 8:24 a.m.

This record is maintained by msoareses  ORCID

Record added: June 2, 2016, 11:16 a.m. Record updated: Feb. 18, 2020, 5:35 p.m. by The FAIRsharing Team.
Show edit history


Record Maintainer


Policy External Cross References

TOP Level Data Transparency: 0: Not TOP compliant

TOP qualifying comments: Data disclosure is required for clinical trials, but "For reports of research other than clinical trials, data sharing statements are encouraged but not required."

Usage / Access



Additional Information